Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Impact Factor:
4.668
5 Year Impact Factor:
5.470
Subscribe to this Journal
Book Proposal
Become an Executive Guest Editor
New Journal Proposal
Become a Section Editor
Become a Reviewer
Join Editorial Board
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Neuropharmacology
,
Volume 3
- Number 1
Editorial [HotTopic: New and Emerging Approaches to Treatment of Schizophrenia (Guest Editors: Gene G. Kinney and P. Jeffrey Conn)]
,
3
(
1
):
1
- 2
Gene G. Kinney and P. Jeffrey Conn
DOI:
10.2174/1570159052773431
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Partial Dopamine Agonists and the Treatment of Psychosis
,
3
(
1
):
3
- 8
Carol A. Tamminga
DOI:
10.2174/1570159052773404
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
,
3
(
1
):
9
- 34
Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn
DOI:
10.2174/1570159052773369
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia
,
3
(
1
):
35
- 43
Gene G. Kinney and Cyrille Sur
DOI:
10.2174/1570159052773387
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia
,
3
(
1
):
45
- 62
David W. Volk and David A. Lewis
DOI:
10.2174/1570159052773396
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
,
3
(
1
):
63
- 71
Cyrille Sur and Gene G. Kinney
DOI:
10.2174/1570159052773413
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
,
3
(
1
):
73
- 85
W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig and J. Marksteiner
DOI:
10.2174/1570159052773440
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Author Index to Volume 2
,
3
(
1
):
87
Bentham Science Publishers
DOI:
10.2174/1570159052773422
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Subject Index to Volume 2
,
3
(
1
):
89
- 93
Bentham Science Publishers
DOI:
10.2174/1570159052773378
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Ferdinando Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
Neurobiology of Mood Disorders
You can view the contents of this eBook
[here]
or purchase it
[here]
.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy